Canada · Delayed Price · Currency is CAD MedMira Statistics
Total Valuation
MedMira has a market cap or net worth of CAD 45.61 million. The enterprise value is 63.03 million.
| Market Cap | 45.61M |
| Enterprise Value | 63.03M |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedMira has 701.73 million shares outstanding. The number of shares has increased by 0.26% in one year.
| Current Share Class | 701.73M |
| Shares Outstanding | 701.73M |
| Shares Change (YoY) | +0.26% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.40% |
| Owned by Institutions (%) | n/a |
| Float | 209.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 123.09 |
| PB Ratio | -1.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 170.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
| Current Ratio | 0.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -34.28% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 8.95% |
| Weighted Average Cost of Capital (WACC) | 7.51% |
| Revenue Per Employee | 7,126 |
| Profits Per Employee | -57,593 |
| Employee Count | 52 |
| Asset Turnover | 0.10 |
| Inventory Turnover | 4.11 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.33% in the last 52 weeks. The beta is 0.79, so MedMira's price volatility has been lower than the market average.
| Beta (5Y) | 0.79 |
| 52-Week Price Change | -13.33% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 49.49 |
| Average Volume (20 Days) | 76,292 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedMira had revenue of CAD 370,568 and -2.99 million in losses. Loss per share was -0.00.
| Revenue | 370,568 |
| Gross Profit | -485,176 |
| Operating Income | -1.97M |
| Pretax Income | -2.99M |
| Net Income | -2.99M |
| EBITDA | -1.94M |
| EBIT | -1.97M |
| Loss Per Share | -0.00 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 17.42M |
| Net Cash | -17.42M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -24.52M |
| Book Value Per Share | -0.03 |
| Working Capital | -23.85M |
Cash Flow
| Operating Cash Flow | -1.19M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 28,227 |
| Net Borrowing | 1.17M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -130.93% |
| Operating Margin | -531.16% |
| Pretax Margin | -808.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedMira does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.26% |
| Shareholder Yield | -0.26% |
| Earnings Yield | -6.57% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedMira has an Altman Z-Score of -53.46 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -53.46 |
| Piotroski F-Score | 4 |